Effects of Eleutheroside B and Eleutheroside E on activity of cytochrome P450 in rat liver microsomes

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Guo, Sixun ^a   Liu, Yan ^a   Lin, Zhiping ^a   Tai, Sheng ^a   Yin, Shuo ^a   Liu, Gaofeng ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cytochrome P450; Eleutheroside B; Eleutheroside E; In vitro

Indexed keywords

CHLORZOXAZONE; CYTOCHROME P450; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; ELEUTHEROSIDE B; ELEUTHEROSIDE E; HERBACEOUS AGENT; TESTOSTERONE; TOLBUTAMIDE; UNCLASSIFIED DRUG; GLUCOSIDE; LIGNAN; PHENYLPROPIONIC ACID DERIVATIVE; SYRINGIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; ELEUTHEROCOCCUS SENTICOSUS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; IN VITRO STUDY; LIVER MICROSOME; MALE; NONHUMAN; RAT; ANIMAL; ENZYMOLOGY; IC50; KINETICS; METABOLISM; PHYTOTHERAPY; WISTAR RAT;

ANIMALS; CHLORZOXAZONE; CYTOCHROME P-450 CYP2C9; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DEXTROMETHORPHAN; GLUCOSIDES; INHIBITORY CONCENTRATION 50; KINETICS; LIGNANS; MALE; MICROSOMES, LIVER; PHENYLPROPIONATES; PHYTOTHERAPY; RATS; RATS, WISTAR; TESTOSTERONE; TOLBUTAMIDE;

EID: 84891636929     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-1     Document Type: Article

References (41)

1. Li T. Siberian ginseng. Horsetechnology 2001, 11:79-84.
2. Pharmacopoeia Commission of People's Republic of China Pharmacopoeia of the People's Republic of China 2010, Beijing: China Medical Science Press, Pharmacopoeia Commission of People's Republic of China.
3. Drozd J, Sawicka T, Prosińska J. Estimation of humoral activity of Eleutherococcus senticosus. Acta Pol Pharm 2002, 59(5):395-401.
4. Han YM, Shi XQ. The research progress of Eleutherococcus senticosus. J Tradit Chin Med 2011, 1:54-55.
5. Zhu YY, Wei XH. Determination of Eleutheroside B and Eleutheroside E in Acanthopanax senticosus by HPLC-PAD. Chin Pharm J 2011, 16(46):1280-1282.
6. Li C, Wang XY, Hu XW. Determination of eleutheroside B in antifatigue fraction of Acanthopanax senticosus by HPLC. Zhongguo Zhong Yao Za Zhi 2008, 23(33):2800-2802.
7. Lee S, Son D, Ryu J. Anti-oxidant activities of Acanthopanax senticosus stems and their lignan components. Arch Pharm Res 2004, 1(27):106-110.
8. Díaz Lanza AM, Abad Martínez MJ, Fernández Matellano L, Recuero Carretero C. Lignan and phenylpropanoid glycosides from Phillyrea latifolia and their in vitro anti-inflammatory activity. Planta Med. 2001, 3(67):219-223.
9. Kapil A, Sharma S. Immunopotentiating compounds from Tinospora cordifolia. J Ethnopharmacol 1997, 2(58):89-95.
10. Cho JY, Nam KH, Kim AR. In-vitro and in-vivo immunomodulatory effects of syringin. J Pharm Pharmacol 2001, 9(53):1287-1294.
11. Niu HS, Liu IM, Cheng JT. Hypoglycemic effect of syringin from Eleutherococcus senticosus in streptozotocin-induced diabetic rats. Planta Med 2008, 2(74):109-113.
12. Niu HS, Hsu FL, Liu IM, Cheng JT. Increase of beta-endorphin secretion by syringin, an active principle of Eleutherococcus senticosus, to produce antihyperglycemic action in type 1-like diabetic rats. Horm Metab Res 2007, 12(39):894-898.
13. Tohda C, Ichimura M, Bai Y. Inhibitory effects of Eleutherococcus senticosus extracts on amyloid beta (25-35)-induced neuritic atrophy and synaptic loss. J Pharmacol Sci 2008, 3(107):329-339.
14. Bai Y, Tohda C, Zhu S. Active components from Siberian ginseng (Eleutherococcus senticosus) for protection of amyloid beta (25-35)-induced neuritic atrophy in cultured rat cortical neurons. J Nat Med 2011, 3-4(65):417-423.
15. Tokiwa T, Yamazaki T, Sakurai S. Anti-inflammatory effect of eleutheroside E from Acanthopanax senticosus. Foods Food Ingred J Jpn 2006, 7(211):576-582.
16. Huang LZ, Wei L, Zhao HF. The effect of Eleutheroside E on behavioral alterations in murine sleep deprivation stress model. Eur J Pharmacol 2011, 2-3(658):150-155.
17. Huang LZ, Huang BK, Ye Q. Bioactivity-guided fractionation for anti-fatigue property of Acanthopanax senticosus. J Ethnopharmacol 2011, 1(133):213-219.
18. Pelkonen O, Urpeinen MT, Hakkola J. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 2008, 10(82):667-715.
19. Gibbson GG, Sheet P. Introduction to Drug Metabolism 1994, London: Blackie Academic and Professional.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 1-2(72):248-254.
21. Bjornsson TD, Callaghan JT, Einolf HJ. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos 2003, 7(31):815-832.
22. Xia CH, Sun JG, Wang GJ. Herb-drug interactions: in vivo and in vitro effect of Shenmai injection, a herbal preparation, on the metabolic activities of hepatic cytochrome P450 3A1/2, 2C6, 1A2, and 2E1 in rats. Planta Med 2009, 3(76):245-250.
23. Babbar S, Chanda S, Bley K. Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicin. Xenobiotica 2010, 12(40):807-816.
24. Fayer JL, Petullo DM, Ring BJ. A novel testosterone 6 beta-hydroxylase activity assay for the study of CYP3A-mediated metabolism, inhibition, and induction in vitro. J Pharmacol Toxicol Methods 2002, 2(46):117-123.
25. Khojasteh SC, Prabhu S, Kenny JR. Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet 2011, 1(36):11-16.
26. Donovan JL, DeVane CL, Chavin KD. Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos 2003, 5(31):519-522.
27. Martignoni M, Groothuis GM, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2006, 2(6):875-894. 10.1517/17425255.2.6.875, 17125407.
28. Turpeinen M, Ghiciuc C, Opritoui M, Tursas L, Pelkonen O, Pasanen M. Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a comparative study in vitro. Xenobiotica 2007, 37(12):1367-1377. 10.1080/00498250701658312, 17943662.
29. Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort. an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 2000, 1(294):88-95.
30. Winitthana T, Niwattisaiwong N, Patarapanich C. In vitro inhibitory effects of asiaticoside and madecassoside on human cytochrome P450. Toxicol In Vitro 2011, 4(25):890-896.
31. Qiu F, Zhang R, Sun J. Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metab Dispos 2008, 7(36):1308-1314.
32. Chatterjee P, Franklin MR. Human cytochrome p450 inhibition and metabolic- intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab Dispos 2003, 11(31):1391-1397.
33. Pekthong D, Martin H, Abadie C. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide. Ethnopharmacol 2008, 3(115):432-440.
34. Pandit S, Mukherjee PK, Ponnusankar S. Metabolism mediated interaction of alpha-asarone and Acorus calamus with CYP3A4 and CYP2D6. Fitoterapia 2011, 3(82):369-374.
35. Liu G, Liu Y, Liu R. Effects of Flos carthami on CYP2D6 and on the Pharmacokinetics of Metoprolol in Rats. Evid Based Complement Alternat Med 2011, 207076. doi:10.1155/2011/207076.
36. Doehmer J, Weiss G, McGregor GP, Appel K. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities. Toxicol In Vitro 2011, 1(25):21-27.
37. Cao Y, Yan X. Study on effects of 36 cases of propofol combined with Acanthopanax Injection for the treatment of insomnia patients. Zhongguo Shi Yong Yi Yao 2011, 14(6):135.
38. Chu X, Liu D. 60 cases of Acanthopanax injection combined with choline injection in the treatment of cervical vertigo. J Tradit Chin Med 2011, 10(20):1699-1700.
39. Gai Y, Zhang T. Clinical study on the effect of Acanthopanax Injection combined with Liposomal Alprostadil in the treatment of stage-IV diabetic nephropathy. J Tradit Chin Med 2011, 4(18):535-537.
40. Du Y. Analysis of literature of 228 cases of adverse drug reactions caused by Acanthopanax Senticosus injection. Zhongguo Lin Chuang Xin Yi Xue 2011, 10(4):946-948.
41. Hu J, Shang H, Li J, Zhang L. 521 cases of adverse drug reactions of Eleutherococcus senticosus Injection based on 944 studies. J Evid Based Med 2010, 2(10):182-188.